Treatment of Nasopharyngeal Cancer in Stage I Nasopharyngeal Carcinoma
Clinical Scenario
Stage I nasopharyngeal carcinoma represents early localised disease. At this stage, the absence of regional nodal involvement or distant spread shapes a distinct management strategy that differs meaningfully from higher-stage presentations.
Treatment Approach
Stage I nasopharyngeal carcinoma is treated with radiotherapy alone. Intensity-modulated radiotherapy (IMRT) is the established modality of choice, delivering targeted radiation to sites of disease as well as potential at-risk regions.
Complete dosing, fractionation, and volume details are in the full structured protocol below.
References
DOI: 10.1016/j.annonc.2020.12.007
- Stage I disease is treated by RT alone, whereas patients with stage II NPC benefit from concurrent chemoradiotherapy (CRT) with cisplatin 30 mg/m²/week when 2D-RT is used [II, B]; a non-significant difference in survival outcomes was shown for CRT versus RT alone when IMRT was adopted [II, B].
- IMRT is the mainstay of treatment [II, A].
View source ↗